-
Jeon Jong-seo praises 'Nothing Serious' director's unique style, humor 코리아헤럴드17:47Jeon Jong-seo has attracted attention for her character’s frank comments about sex in romantic comedy “Nothing Serious,” but for her the role was all abou...
-
Lee Jae-myung, "I Will Personally Meet with Biden and Kim Jong-un to Solve the North Korean Nuclear Problem" 경향신문17:31[경향신문] On November 25, Lee Jae-myung, the presidential candidate of the ruling Democratic Party of Korea, spoke on his policy on North Korea and said, “
-
Government to Announce Comprehensive Measures Against COVID-19 Next Monday: Discussions on Expanding the Vaccine Pass Underway 경향신문17:29[경향신문] The government will announce comprehensive measures for stronger disease control in response to the deteriorating outbreak of COVID-19 on November
-
[Eye interview] 'Squid Game' VIP actors address criticism of their performance 코리아헤럴드16:29John D. Michaels and Daniel C. Kennedy faced harsh criticism after appearing on the Netflix global sensation “Squid Game” as two of the VIPs. They addresse
-
The Frame TV becomes Samsung Elec's first single-year million-seller 매일경제13:24“The Frame” premium TV has become Samsung Electronics Co.’s first single-year million-seller thanks to surge in sales at home as well as North America and
-
Korean startups dive deeper into precision data sea for value-added solution 매일경제13:24South Korean startups are moving beyond the so-called big data to more accurate and value-added ¡®deep data¡¯ to meet the evolving needs of the marketpla
-
CRISPR gene editing firm ToolGen boasts of growth potential as its moves to Kosdaq Dec 매일경제13:15South Korean CRISPR gene-editing company ToolGen Inc. moving to Kosdaq from startup-focused Konex bourse early next month claimed its growth potential was as
-
PUBG: New State records 43.6 mn worldwide downloads in first 2 weeks 매일경제13:15PUBG: New State, Krafton’s new mobile game released on Nov. 11, topped 43.6 million worldwide downloads in just two weeks, according to App Annie. It is No.
-
Ildong Pharm kicks off P2/3 clinical trial of oral Covid-19 cure in Korea 매일경제13:12Ildong Pharmaceutical has started a Phase 2/3 clinical trial of S-217622, an investigational oral medication developed by its Japanese partner Shionogi Pharm
-
SK Energy to test sell carbon neutral petroleum products 매일경제13:06SK Energy under Korean refiner SK Innovation will run a pilot program of selling carbon neutral petroleum products for three months until February next year
-
Bioneer scales up production of DNA/RNA extraction kits 매일경제13:00Bioneer Corp. has completed upgrading its global center that will serve as the company’s base to roll out next-generation DNA/RNA extraction kits with daily
-
Goldman Sachs testimony suggests Samsung Elec chief Lee's active role in business deals 매일경제13:00Samsung Electronics Co.’s Vice Chairman Jay Y. Lee proved to be more than a backseat driver in management affairs of Korea’s most valuable company as the c
-
KTB Investment & Securities brings Eugene Savings Bank onboard 매일경제12:51Eugene Savings Bank gained authority go-ahead to go under KTB Investment & Securities. KTB has completed payment of 200.3 billion won ($167.9 million) to acq
-
Korea's long-haul LCC Air Premia to fly to America, Europe at fares 20-30% below average 매일경제12:51South Korea’s fledgling low-cost carrier (LCC) Air Premia will differentiate its long-haul service with 30 percent cheaper flights yet in seats and service
-
Samsung Biologics to produce mRNA vaccine for U.S. GreenLight 매일경제12:06South Korea’s Samsung Biologics and U.S. biotech company GreenLight Biosciences have teamed up to increase access to Covid-19 vaccines across Africa. Samsun
현재 페이지1
2